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ABSTRACT 
DNA methylation at CpG rich regions often occurs at tumor suppressor gene promoters, resulting in reduced gene 
expression and final carcinogenesis. Hypermethylation of tumor suppressor genes, including DAPK-1 and 
RASSF-1 genes, have been found in patients with bladder carcinoma (BC) in some western countries. Reactive 
oxygen species (ROS) was reported to play a causative role in gene hypermethylation. In this study, we detected 
the methylation status and expression of DAPK1 and RASSF-1 genes in tissue samples from Chinese BC pa-
tients, using methylation-specific PCR, reverse transcription PCR and western blotting. Further, we examined the 
ability of dioscin, a natural antioxidant, to regulate methylation status and expression of DAPK-1 and RASSF-1 
genes in BC cell lines. In our results, DAPK-1 and RASSF-1 genes showed higher methylation level and lower 
express level in BC tissues than matched normal tissues. Treatment with dioscin decreased viability of BC 5637 
and T24 cells, but not non-cancer bladder epithelial cell, SV-HUC-1. Dioscin triggered demethylation of DAPK1 
and RASSF-1 genes in T24 cells and increased the gene and protein expression in 5637 and T24 cells. Both 
dioscin and substituted antioxidants (N-acetyl cysteine and Vitamin E) decreased intracellular ROS, but the effect 
of dioscin was abolished by adding H2O2. Similar to dioscin, the substituted antioxidants also induced the gene 
demethylation and T24 cell apoptosis. Co-treatment with dioscin and H2O2 had no such effects. Collectively, di-
oscin induces demethylation of DAPK-1 and RASSF-1 genes via the antioxidant capacity, resulting in apoptosis 
of bladder cancer T24 cells or inhibitory cell viability. 
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INTRODUCTION  
Bladder carcinoma (BC) is one of most 
common malignancy in the economically ad-
vanced countries, and the incident of BC dis-
ease has been increasing rapidly in some de-
veloping countries, like China, in recent years 
(Xu et al., 2016; Christoph et al., 2006a). The 
pathogenesis of BC remains unclear, but re-
cent bioinformatics analysis and epidemio-
logical study indicate that abnormal hyper-
methylation in promoter regions of many tu-
mor suppressor genes blocks their expression, 
which attenuates effects of their gene prod-
ucts against tumorigenesis, resulting in in-
creased risk of BC occurrence (Christoph et 
al., 2006b; Jabłonowski et al., 2011; Meng et 
al., 2012).  
DAPK-1 (Death-associated protein ki-
nase-1) and RASSF-1 (Ras-association do-
main family 1 isoform A) genes have been 
identified as important tumor suppressor 
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gene, and down-regulation in their gene ex-
pression has been observed in various cancers 
(Christoph et al., 2006a). The product of the 
DAPK-1 gene is considered to be a positive 
mediator of apoptosis (Christoph et al., 
2006a). One important mechanism by which 
tumor necrosis factor-α promotes apoptosis of 
tumor cells is through stimulating DAPK-1 
functions (Turner-Brannen et al., 2011). 
RASSF-1 gene exerts multiple actions 
against cancer formation and progression, via 
regulating cell death, cell cycle, and microtu-
bule formation. An investigation undertaken 
in 42 patients of Poland with non-invasive BC 
found that hypermethylation in promoter re-
gions of DAPK-1 gene accounts 64.3 % of 
patients (Jabłonowski et al., 2011). In an in-
dependent study, using demethylating agents 
(5-Aza-2’-deoxycytidine and zebularine) re-
stored DAPK-1 expression and effectively re-
tarded growth of BC cells (Christoph et al., 
2006a). Elevated promoter methylation of 
RASSF-1 gene was also observed in Amer-
ican BC patients by Meng et al. (2012) who 
found that 73 % (30/41) of the transitional cell 
carcinoma, 100 % (3/3) of the squamous cell 
carcinoma, and 100 % (4/4) of the small cell 
carcinoma had the promoter methylation. The 
methylation ratio in BC tissues is much higher 
than that in normal adjacent tissues which 
only 6 % (1/16) of the methylation (Meng et 
al., 2012). These data collectively suggest that 
promoter hypermethylation of DAPK1 and 
RASSF-1 genes is probably an important 
reason for their down-regulation in gene 
level, and is presumably associated with BC 
development and progression, whereas it is 
currently unknown about which reasons cause 
the promoter hypermethylation in BC.  
Reactive oxygen species (ROS) are a type 
of chemically reactive molecules containing 
oxygen, generated from both endogenous and 
exogenous origin. Abnormally elevated ROS 
has been closely linked with carcinogenesis, 
probably due to induction of epigenetic alter-
ations (Wu and Ni, 2015). Ongoing re-
searches indicate that ROS contributes pro-
moter hypermethylation of many genes, at 
least, though following three approaches:  
1) ROS can function as catalysts of DNA 
methylation via induction of a series of 
chemical reactions;  
2) Expression of DNA methyltransferases 
(DNMT) can be up-regulated by ROS, 
such as superoxide anion and hydrogen 
peroxide (H2O2);  
3) DNA-induced DNA damage facilitates the 
recruitment of DNMT to DNA and the 
formation of DNMT-containing com-
plexes (Wu and Ni, 2015).  
Given the promoting effect of ROS on 
gene promoter hypermethylation, using some 
antioxidants to scavenge ROS is presumably 
an effective method to attenuate or reverse the 
ROS-induced promoter hypermethylation and 
restore expression level of antioncogene, 
thereby repressing tumor growth and progres-
sion.  
Dioscin is a natural antioxidant widely 
present in some medicinal herbs. Pharmaco-
logical studies have demonstrated that dioscin 
has activity against various cancers, including 
cervical carcinoma, gastric cancer, lung can-
cer and colon cancer (Zhao et al., 2016; Tong 
et al., 2014; Wei et al., 2013). But there is cur-
rently no study investigating impact of dios-
cin on BC. In addition, to our knowledge, no 
research has implicated the antioxidative ac-
tivity of dioscin in regulation of gene methyl-
ation, and it is barely unknown about whether 
dioscin has the ability to store expression 
level of antioncogene that is methylated in 
promoter region, through anti-oxidative ac-
tion. In this study, we detected the methyla-
tion status and expression of DAPK1 and 
RASSF-1 genes in tissue samples from Chi-
nese BC patients, using methylation-specific 
PCR (MSP-PCR), reverse transcription PCR 
(RT-PCR) and western blotting. Further, we 
examined the ability of dioscin to regulate 
methylation status and expression of DAPK-
1 and RASSF-1 genes in BC cell lines and 
the association of this ability with the anti-ox-
idative capacity. 
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MATERIALS AND METHODS 
Tissue sample and ethics statement 
BC and adjacent normal tissue samples 
were obtained from patients (Table 1) who 
underwent operation at the Third Xiangya 
Hospital of Central South University. The 
samples were frozen in liquid nitrogen imme-
diately after surgery. All patients provided 
written informed consent in compliance with 
the code of ethics of the World Medical As-
sociation (Declaration of Helsinki; Ferney-
Voltaire, France). This study was approved by 
the Ethics Committee of Xiangya School of 
Medicine (Changsha, People’s Republic of 
China).  
 
Table 1: Clinicopathological characteristics of BC 
patients  
Factors Patients (n = 25)
Gender 
Male 19 
Female 6 
TNM classification 
Depth of wall  
invasion 
Nmibc  
(Ta, Tis and T1) 13 
Mibc  
(T2, T3 and T4) 12 
Lymph node  
metastasis  
Positive 14 
Negative 11 
Distant metastasis 
Positive 7 
Negative 18 
Differentiation  
status 
Well 6 
Moderate 10 
Poor 9 
NMIBC: normuscle invasive bladder cancer;  
MIBC: muscle invasive bladder cancer 
 
Cell culture and treatment 
BC cell lines, including 5637 and T24 
cells, and immortalized epithelial cell line of 
urinary bladder, SV-HUC-1 cells, were obtain 
from the American Type Culture Collection 
(ATCC, Manassas, VA, USA). All the cell 
lines were maintained at 37° C in RPMI-1640 
medium (GibcoR; Life Technologies, Carls-
bad, CA, USA) supplemented with 10 % fetal 
bovine serum (Invitrogen, Life Technologies, 
Carlsbad, CA, USA). These cells were treated 
with different doses of dioscin (0, 0.2, 1, 5 and 
25 μg/mL) for 48 h. Besides, T24 cells were 
exposed to mixed antioxidants, containing 10 
μg/mL N-acetyl cysteine and 20 μg/mL Vita-
min E, or combination of 5 μg/mL dioscin and 
5 μM/mL H2O2 for 48 h. All these agents 
were purchased from the Sigma Company (St. 
Louis, MO, USA), unless otherwise specified.  
 
MSP-PCR analysis 
MSP-PCR analysis was performed to de-
termine methylation status of the promoter re-
gion of DAPK-1 and RASSF-1 genes in tis-
sue samples and cell lines. Genomic DNA 
from tissue samples and cell lines was sub-
jected to bisulfite modification using the 
CpGenome DNA Modification Kit (Invitro-
gen) according to the manufacturer’s instruc-
tions. Primers were designed to locate on the 
5’-upper region of each promoter, which can 
distinguish unmethylated (U) and methylated 
(M) alleles (Table 2). Cycling conditions 
were initial denaturation at 95˚C for 3 min, 40 
cycles of 94° C for 30 sec, 65 (M) or 63° C 
(U) for 30 sec and 72° C for 30 sec. PCR 
products were separated on 4 % agarose gels, 
stained with ethidium bromide and visualized 
under UV illumination.  
 
RT-PCR analysis 
RT-PCR was performed to determine ex-
pression levels of DAPK-1 and RASSF-1 
genes in indicated tissues and cells. RNA was 
isolated from the tissues and cells using TRI-
ZOL (Takara Corp., Tokyo, Japan) according 
to the protocols supplied by the manufacturer, 
before RNA was reverse transcribed using the 
Reverse Transcription Kit (Applied Biosys-
tems Inc., Foster City, CA, USA). The real-
time PCR primers used to quantify DAPK-1, 
RASSF-1 and β-actin gene expression:   
DAPK-1 promoter forward,   
5'-ATGATCCCACGTCAATCCAT-3'  
and DAPK-1 promoter reverse,   
5'-CCACCAGGACAACTTGGAGT-3'; 
RASSF-1 promoter forward,   
5'- GCAGGCATTGAGGAAGAGTC-3' and 
RASSF-1 promoter reverse,   
5'- GTGCCCACATTCACACAGAC-3';   
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β-actin promoter forward,   
5'- CATTAAGGAGAAGCTGTGCT-3'   
and β-actin promoter reverse,   
5'- GTTGAAGGTAGTTTCGTGGA-3'.  
The real-time PCR was performed using 
FastStart SYBR-Green Master (cat. no. 
04673484001) on a LightCycler480 system. 
The expression of DAPK-1 and RASSF-1 
genes were normalized to that of endogenous 
β-actin gene. 
 
Western blot assay 
DAPK-1 and RASSF-1 protein levels in 
indicated tissues and cells were evaluated by 
Western blot assay. Equal amounts (20 μg) of 
total protein extracted from the tissues and 
cells was loaded and separated on SDS-PAGE 
gels. Proteins were transferred to nitrocellu-
lose membranes and subsequently immunob-
lotted with the primary antibodies, including 
anti-DAPK-1, anti-RASSF-1, and anti-β-ac-
tin antibodies (Santa Cruz, CA, USA). Mem-
branes were washed with TBS-T, and then in-
cubated with secondary antibody. Proteins 
were detected using the Amersham enhanced 
chemiluminescence system (Pierce, Rock-
ford, IL, USA) according to the manufac-
turer’s instructions. The blots were visualized 
by enhanced chemiluminescence, using Fuji 
medical X-ray film (Fujiilm, Tokyo, Japan).  
 
Cell viability assay 
5637, T24 and SV-HUC-1 cells were 
seeded in 96-well plates in 100 μL complete 
medium and allowed to attach overnight. Af-
ter the cells were subjected to diverse treat-
ments, 3-(4,5-dimethyl-2-thiazolyl)-2,5-di-
phenyl-2H-tetrazolium bromide (MTT) 
(20 μL at 5 mg/mL) was added to each well. 
The medium was removed 4 h later and 
150 μL dimethylsulfoxide was added subse-
quently to terminate the reaction. The plates 
were read with a microplate reader at 570 nm. 
 
Flow cytometry analysis of apoptotic cells 
Apoptosis was detected using annexin V-
FITC/propidium iodide (PI) staining followed 
by flow cytometry. After subjected to diverse 
treatments, T24 cells were incubated with an-
nexin V-FITC and PI at room temperature for 
15 min in the dark. The cells were collected 
and analyzed by a FACSCanto II flow cytom-
eter (Becton Dickinson Immunocytometry 
System).  
 
 
Table 2: Primers sequence for MSP-PCR analysis 
Gene name Primer sequence (5'~3') Amplified fragment length (bp) 
Annealing  
temperature (Ԩ)
DAPK-1 (M)-F TGTAGTTTTAGTTATTGGGGAGGTC
115 58 
DAPK-1 (M)-R TTTAAAACGAAATCTCACTCTATCG 
DAPK-1 (U)-F TAGTTTTAGTTATTGGGGAGGTTGA
115 58 
DAPK-1 (U)-R AAAACAAAATCTCACTCTATCACC 
RASSF-1α (M)-F GATTGTGTGGATAGGTGAGTAGTTC
121 57 
RASSF-1α (M)-R AAAAAAAACTAAAAACAAAAACGTT 
RASSF-1α (U)-F TTGTGTGGATAGGTGAGTAGTTTGA
121 57 
RASSF-1α (U)-R AAAAAAAACTAAAAACAAAAACATT 
Primers were designed to locate on the 5’-upper region of each promoter for distinguishing unmethylated (U) and methylated 
(M) alleles 
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Intracellular ROS and reduced glutathione 
(GSH) measurement 
The intracellular ROS level in cells was 
quantified using Reactive Oxygen Species 
Assay Kit (Beyotime, Nanjing, China). After 
washing with PBS, T24 cells were suspended 
in the 2′,7′-dichlorofluorescin diacetate 
(DCFH-DA) solution (10 μM) at 107/ml and 
incubated at 37° C for 20 min. Fluorescent in-
tensity of DCFH-DA in the cells was detected 
by a fluorospectrophotometer (F-4000; Hita-
chi, Ltd., Tokyo, Japan). Glutathione Quanti-
fication Kit (Jianchen, Co., Nanjing, China) 
was used for the intracellular GSH measure-
ment. This kit employs a fundamental reac-
tion in which 5,59-dithiobis-2-nitrobenzoic 
acid (DTNB) and GSH react to generate 2-ni-
tro-5-thiobenzoic acid and glutathione disul-
fide (GSSG). Because 2-nitro-5-thiobenzoic 
acid is a yellow product, the GSH concentra-
tion in the cell sample can be detected at 405 
nm. 
 
Statistical analysis 
Statistical analysis was performed using 
SPSS computer software (Version 12, SPSS, 
Chicago, USA). Statistical significance was 
determined using a two-tailed Student’s t-test 
and standard deviations. All P-values < 0.05 
were considered statistically significant. 
 
RESULTS 
Methylation and expression of DAPK-1 and 
RASSF-1 genes in BC and adjacent  
normal tissues 
BC tissues (n = 25) and adjacent normal 
tissues (n = 25) were collected and subjected 
to MSP-PCR to investigate promoter methyl-
ation status of DAPK-1 and RASSF-1 genes 
in these tissues. Each tissue sample experi-
enced MSP-PCR test using both unmethyl-
ated (U) and methylated (M) primers. Figure 
1A expresses the representative data. We 
found that the methylation frequencies of 
DAPK-1 and RASSF-1 genes in BC tissues 
are 64 % (15/25) and 80 % (20/25), respec-
tively. In contrast, no methylation in promoter 
regions of DAPK-1 gene was detected in 
matched normal tissues, and only one case of 
the normal tissue sample showed the RASSF-
1 gene methylation. Further, we examined 
the expression of DAPK-1 and RASSF-1 
genes in the tissues using RT-PCR and West-
ern blotting. As Figure 1B and 1C shown, 
DAPK-1 and RASSF-1 expressions in both 
gene and protein levels were significantly 
higher in BC tissues than in adjacent normal 
tissues (p < 0.05).  
 
Effect of dioscin on viability of BC and 
marched normal cells  
BC cell lines, including 5637 and T24 
cells, and immortalized epithelial cell line of 
urinary bladder, SV-HUC-1 cells, were 
treated with different doses of dioscin for 48h. 
Cell viability test showed that dioscin caused 
a dose-dependent reduction in cell viability of 
5637 and T24 cells (Figure 2). 5 and 25 
μg/mL dioscin significantly decreased cell vi-
ability of both 5637 and T24 cells, as com-
pared with corresponding untreated groups (p 
< 0.05). Except for 0.2 μg/mL dioscin, which 
slightly elevated the cell SV-HUC-1 viability, 
dioscin treatment induced different degrees of 
reductions in the cell viability. However, 
these reductions did not reach to statistical 
significance in despite of cell exposure to 
high concentrations of dioscin.  
 
Effect of dioscin on methylation and  
expression of DAPK-1 and RASSF-1 
genes in BC and marched normal cells 
Results in Figure 3A indicated that there 
is not methylation in promoter regions of 
DAPK-1 and RASSF-1 genes in SV-HUC-
1 and 5637 cells. Adding dioscin, regardless 
of concentrations, to the cells did not altered 
the unmethylated status. In contrast, DAPK-1 
and RASSF-1 genes in T24 cells were meth-
ylated and hemi-methylated, respectively. 
Treatment of T24 cells with 5 or 25 μg/mL di-
oscin for 48h changed methylated status of 
DAPK-1 gene to hemi-methylated status. 
hemi-methylated RASSF-1 gene was 
switched to be unmethylated, after exposure 
to 5 or 25 μg/mL dioscin for 48h. RT-PCR 
was further performed to detect the 
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Figure 1: Methylation and expression of DAPK-1 and RASSF-1 genes in BC and adjacent normal 
tissues  
BC tissues (n = 25) and adjacent normal tissues (n = 25) were collected and subjected to MSP-PCR (A), RT-PCR (B) and Western 
blot (C) assays to investigate methylation status and expression of DAPK-1 and RASSF-1 genes in these tissues.  
U: unmethylated; M: methylated; DAPK1: Death-associated protein kinase-1; RASSF-1 : Ras-association domain family 1 iso-
form A. *P < 0.05 vs. control group. 
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alteration in DAPK-1 and RASSF-1 gene 
expression after the treatment with dioscin. 
When no dioscin was added to the cells, SV-
HUC-1 cells showed higher DAPK-1 and 
RASSF-1 gene expression than 5637 and 
T24 cells. Supplement with dioscin had no 
significant effect on DAPK-1 and RASSF-1 
gene expression in SV-HUC-1 cells, while 5 
and 25 μg/mL dioscin raised DAPK-1 and 
RASSF-1 gene expression in both 5637 and 
T24 cells.  
 
 
 
Figure 2: Effect of dioscin on viability of BC and 
marched normal cells  
BC cell lines, including 5637 and T24 cells, and immortalized 
epithelial cell line of urinary bladder, SV-HUC-1 cells, were 
treated with different doses of dioscin for 48h. Experiments 
were repeated at least three times. Each bar represents the 
mean of three independent experiments. #P < 0.05 and 
*P < 0.05 vs. control group. 
 
Figure 3: Effect of dioscin on methylation and expression of DAPK-1 and RASSF-1 genes in BC and 
marched normal cells 
BC cell lines, including 5637 and T24 cells, and immortalized epithelial cell line of urinary bladder, SV-HUC-1 cells, were treated 
with different doses of dioscin for 48h. Then, MSP-PCR (A), RT-PCR (B) were performed to investigate methylation status and 
expression of DAPK-1 and RASSF-1 genes in these cells. U: unmethylated; M: methylated; DAPK1: Death-associated protein 
kinase-1; RASSF-1 : Ras-association domain family 1 isoform A. Experiments were repeated at least three times. Each bar 
represents the mean of three independent experiments. #P < 0.05 and *P < 0.05 vs. control group. 
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Antioxidant capacity of dioscin is associ-
ated with the regulation of DAPK-1 and 
RASSF-1 gene methylation in T24 cells  
To understand whether antioxidant capac-
ity of dioscin is associated with the regulation 
of methylation status of DAPK-1 and 
RASSF-1 genes in T24 cells, we treated T24 
cells with other antioxidants, which were con-
sisted of 10 μg/mL N-acetyl cysteine and 20 
μg/mL Vitamin E, or with combination of 5 
μg/mL dioscin and 5 μM/mL H2O2. Examina-
tion of intracellular ROS showed that treat-
ment with dioscin alone or the substituted an-
tioxidants dramatically diminished ROS 
level, compared with control gourp (p < 0.05, 
Figure 4). Concurrent supplement with dios-
cin and H2O2 just caused a marginal elevation 
of intracellular ROS. GSH is an important en-
dogenous antioxidant against ROS, thus it is 
commonly used as a mark to evaluate anti-
/oxidative status in cells. It was found that in-
tracellular GSH was notably increased after 
treatment with dioscin alone or the substituted 
antioxidants (p < 0.05). No significant altera-
tion in GSH level was observed with concur-
rent supplement with dioscin and H2O2. MSP-
PCR showed the substituted antioxidants 
changed methylated status of DAPK-1 gene 
to hemi-methylated status in T24 cells, as 
similar as the effect of dioscin (Figure 5A). 
H2O2 abrogated dioscin-induced alteration of 
DAPK-1 gene from methylated status to 
hemi-methylated status. hemi-methylated 
RASSF-1 gene is switched to be unmethyl-
ated by the substituted antioxidants. Combi-
nation of dioscin with H2O2 failed to lead to 
the alteration of hemi-methylated RASSF-1 
gene to be unmethylated. We further assessed 
DAPK-1 and RASSF-1 expression in gene 
and protein levels via RT-PCR and Western 
blotting. As shown in Figure 5B, both dioscin 
and substituted antioxidants increased 
DAPK-1 and RASSF-1 gene expression 
(p < 0.05). H2O2 abolished effect of dioscin 
on the up-regulation of DAPK-1 and RASSF-
1 genes. DAPK-1 and RASSF-1 protein 
expression was increased with adding dioscin 
or substituted antioxidants to T24 cells (p < 
0.05). Co-treatment with dioscin and H2O2, 
however, was unable to increased DAPK-1 
and RASSF-1 protein expression.  
 
Alteration of cell viability and apoptosis 
rate after various treatments  
Cell viability of T24 was significantly de-
creased by treatment with dioscin or substi-
tuted antioxidants, compared with control 
(p < 0.05). Co-treatment with dioscin and 
H2O2 further attenuated the cell viability 
(p < 0.01). Apoptosis rate was increased after 
treatment with dioscin or substituted antioxi-
dants (p < 0.05). H2O2 enhanced the effect of 
dioscin on induction of apoptosis.  
 
 
Figure 4: Intracellular ROS and GSH levels of BC 
T24 cells following diverse treatments.  
BC T24 cells were treated with 5μg/mL dioscin, mixed antioxi-
dants (10 μg/mL N-acetyl cysteine and 20 μg/mL Vitamin E) or 
combination of 5μg/mL dioscin and 5 μM/mL H2O2 for 48h, fol-
lowed by measurements of intracellular ROS and GSH levels. 
Dio: dioscin; AT: antioxidants composed of 10 μg/mL N-acetyl 
cysteine and 20 μg/mL Vitamin E; Dio+ H2O2: co-treatment 
with dioscin and H2O2. Experiments were repeated at least 
three times. Each bar represents the mean of three independ-
ent experiments. *P < 0.05 vs. control group. 
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DISCUSSION 
BC is one the most frequent urogenital 
malignancies in developed counties and some 
developing countries with rapid economic de-
velopment (Xu et al., 2016; Christoph et al., 
2006a). There is evidence that modern life-
styles have strong association with the high 
incident of BC, which can induce epigenetic 
transformation, resulting in aberrant expres-
sion of some cancer-related genes (Ro-
magnolo et al., 2016; Shankar et al., 2016). 
Epigenetic control of gene transcription in-
cludes methylation of the DNA and covalent 
modifications, such as acetylation and meth-
ylation, of chromatin’s histone proteins. Hy-
permethylation in promoter CpG  islands and
 
 
Figure 5: Methylation status and expression of DAPK-1 and RASSF-1 genes in BC T24 cells following 
various treatments 
BC T24 cells were treated with 5μg/mL dioscin, mixed antioxidants (10 μg/mL N-acetyl cysteine and 20 μg/mL Vitamin E) or 
combination of 5μg/mL dioscin and 5 μM/mL H2O2 for 48h, followed by measurements of MSP-PCR (A), RT-PCR (B) and Western 
blot (C) assays to investigate methylation status and expression of DAPK-1 and RASSF-1 genes in cells. U: unmethylated; M: 
methylated; DAPK1: Death-associated protein kinase-1; RASSF-1 : Ras-association domain family 1 isoform A. Dio: dioscin; 
AT: antioxidants composed of 10 μg/mL N-acetyl cysteine and 20 μg/mL Vitamin E; Dio+ H2O2: co-treatment with dioscin and 
H2O2. Experiments were repeated at least three times. Each bar represents the mean of three independent experiments. *P < 
0.05 vs. control group.  
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Figure 6: Alteration of cell viability and apoptosis rate after various treatments  
BC T24 cells were treated with 5μg/mL dioscin, mixed antioxidants (10 μg/mL N-acetyl cysteine and 20 μg/mL Vitamin E) or 
combination of 5μg/mL dioscin and 5 μM/mL H2O2 for 48h, followed by measurements of cell viability and apoptosis rate. Dio: 
dioscin; AT: antioxidants composed of 10 μg/mL N-acetyl cysteine and 20 μg/mL Vitamin E; Dio+ H2O2: co-treatment with dioscin 
and H2O2. Experiments were repeated at least three times. Each bar represents the mean of three independent experiments. *P 
< 0.05 and **P < 0.01 vs. control group.  
 
 
 
diminished expression of antioncogenes have 
been reported to be present in BC. Hypometh-
ylation of the genomic DNA is relevant for 
gene silencing, leading to the functional inac-
tivation. Previous researches have docu-
mented that hypermethylation of DAPK-1 
and RASSF-1 genes was found in BC tis-
sues from Poland and American patients, re-
spectively (Jabłonowski et al., 2011; Meng et 
al., 2012). Similarly, this study revealed that 
promoter methylation levels of DAPK-1 and 
RASSF-1 genes in BC tissues from Chinese 
patients were significantly elevated when 
compared to those in adjacent normal tissues. 
These studies imply that hypermethylation of 
DAPK-1 and RASSF-1 genes is probably a 
common event in BC patients worldwide. 
Further, we uncovered that DAPK-1 and 
RASSF-1 expression in both gene and pro-
tein levels were notably decreased in BC tis-
sues, compared with normal bladder tissues. 
Thus, we suggest that hypermethylation of 
DAPK-1 and RASSF-1 genes is likely asso-
ciated with their down-regulation.  
Dioscin is a natural antioxidant, exerting 
anti-cancer activity, but the effect of dioscin 
has never been investigated in BC. In this 
study, we found that dioscin notably de-
creased viability of BC 5637 and T24 cells, 
but marginally inhibited viability of bladder 
non-cancer cells (SV-HUC-1). These data in-
dicated that dioscin has preferential growth 
inhibitory activity on BC cells than non-can-
cer bladder cells. One possible reason is that 
dioscin could up-regulate DAPK-1 and 
RASSF-1 expression in 5637 and T24 cells, 
but not in SV-HUC-1 cells, as observed in our 
finding. DAPK-1 and RASSF-1 genes play 
important role in growth inhibition and apop-
tosis of tumor cells. DAPK1 is a kinase in-
volved in the p53-dependent apoptosis path-
way and the modulation of apoptosis initiated 
by several death-inducers such as TNF-α and 
INF-γ (Tian et al., 2015; Kwon et al., 2016). 
In various cancers, including ovarian endo-
metriosis and endometrioid carcinoma, non-
small cell lung cancer and cervical cancer, 
DAPK1 is down-regulated and thereby con-
tributes to reduced sensitivity to apoptotic sig-
nal and increased tumor cell survival and pro-
liferation, causing cancer development and 
recurrence (Christoph et al., 2006; Tian et al., 
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2015; Kwon et al., 2016). RASSF1 pro-
moter methylation has been used as a bi-
omarker for detecting field cancerization in 
non-invasive breast cancer and as a prognos-
tic factor in invasive breast cancer (Spitzwie-
ser et al., 2015; Shakeri et al., 2016). Previous 
studies have documented lower expression of 
RASSF1 in non-small cell lung cancer, 
esophageal squamous cell carcinoma and lac-
rimal gland carcinoma (Zeng et al., 2015). Pa-
tients with lower RASSF1 expression 
showed a higher recurrence probability and 
unfavorable prognosis (Zeng et al., 2015). 
Restoration of RASSF1 expression signifi-
cantly inhibited gastric cancer cell viability, 
colony formation and induced the cell cycle 
arrest and apoptosis (Zhou et al., 2015). 
Over-production of ROS has been closely 
linked with gene hypomethylation, although 
the underlying mechanisms are incompletely 
understood. Zhou et al (2016) found that long-
term exposure to PM2.5, namely the fine par-
ticulate matter, suppressed p53 expression in 
lung cancer cells, via ROS-Akt-DNMT3B 
pathway-mediated promoter hypermethyla-
tion. In addition, exposure to low-dose Fe-ion 
radiation causes ROS production, further re-
sulting in increased DNA methylation in 
mouse bone marrow hematopoietic progeni-
tor and stem cells (Miousse et al., 2014). Alt-
hough it is unclear about whether the hyper-
methylation of DAPK-1 and RASSF-1 
genes in BC cells is correlated with increased 
ROS, our study showed that treatment of BC 
T24 cells with dioscin induced the gene de-
methylation. Similar outcome was also ob-
served with the substitute antioxidants com-
posed of N-acetyl cysteine and Vitamin E. 
More importantly, concurrent treatment with 
a oxidant, H2O2, abolished the dioscin anti-
oxidative capacity and the effect on the gene 
demethylation. These evidence indicated that 
ability of dioscin to gene demethylation is as-
sociated with the anti-oxidative capacity.  
In T24 cells, promoter demethylation of 
DAPK-1 and RASSF-1 genes induced by 
both dioscin and the antioxidants is accompa-
nied with the gene up-regulation. H2O2 abol-
ished the effect of dioscin on the gene de-
methylation, which reversed DAPK-1 and 
RASSF-1 expression that is enhanced by di-
oscin. These data suggest that dioscin up-reg-
ulating DAPK-1 and RASSF-1 expression is 
dependent of the demethylation action. Un-
likely, there is no methylation in promoter re-
gions of DAPK-1 and RASSF-1 genes in 
BC 5637 cells, thus the up-regulated DAPK-
1 and RASSF-1 expression induced by dios-
cin in the cells is probably not related to the 
demethylation activity. Further study is 
needed to clarify the mechanism by which di-
oscin up-regulated DAPK-1 and RASSF-1 
expression in BC 5637 cells. An unexpected 
result is that co-treatment with dioscin and 
H2O2 had a better effect on reduction of cell 
viability and induction of cell apoptosis than 
treatment with dioscin alone, even though 
H2O2 abrogated effect of dioscin on the de-
methylation of DAPK-1 and RASSF-1 
genes. It should be noted that H2O2 originally 
has strong ability to induce cell apoptosis 
through causing cell damages in cell mem-
brane and DNA and stimulating multiple 
apoptotic signal pathways, which may explain 
the result.  
In summary, this study provided direct ev-
idence that dioscin suppresses viability of BC 
5637 and T24 cells and increases the apopto-
sis rate, via the up-regulation of DAPK1 and 
RASSF-1 genes. More importantly, we ver-
ified that dioscin-induced up-regulation of 
DAPK1 and RASSF-1 genes in BC T24 
cells is related to the induction of gene de-
methylation by the anti-oxidative activity. 
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